Related Experiment Video
Updated: Mar 29, 2026
13:04
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
14.0K
FAT1 Is Differentially Expressed in Cancers Affecting the Serosal Cavities
Ben Davidson1,2, Arild Holth3
1Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway, bend@medisin.uio.no.
Summary
FAT1 protein is frequently found in gastrointestinal, lung, and breast cancers but rarely in tubo-ovarian carcinoma effusions and mesothelioma. This expression pattern may aid cancer diagnostics.
Area of Science:
- Oncology
- Cancer Diagnostics
- Protein Expression Analysis
Background:
- FAT1 mutations are prevalent across various cancer types.
- Understanding FAT1 protein expression is crucial for cancer diagnosis.
Purpose of the Study:
- To investigate the diagnostic utility of FAT1 protein expression in serosal cavity cancers.
- To analyze FAT1 expression patterns in effusions and surgical specimens.
Main Methods:
- Immunohistochemistry was used to assess FAT1 protein expression.
- Analyzed 256 effusions from various cancer types, including tubo-ovarian, breast, mesothelioma, uterine, lung, and gastrointestinal carcinomas.
- Compared effusion results with matched surgical specimens for breast and tubo-ovarian carcinomas.
Main Results:
- FAT1 expression was highest in gastrointestinal (92%), lung (60%), and breast (55%) carcinomas.
- Tubo-ovarian carcinoma effusions showed low FAT1 expression (5%), contrasting with surgical specimens (28%).
- Mesotheliomas were uniformly negative for FAT1 expression (0%).
Conclusions:
- FAT1 protein expression differs significantly across cancer types in serosal cavities.
- FAT1 is a potential biomarker for distinguishing gastrointestinal, lung, and breast cancers from tubo-ovarian carcinomas and mesotheliomas.
- Further research is needed to confirm the diagnostic value of FAT1 in clinical practice.
